Picumeterol

This classification denotes a beta-adrenergic agonist with the molecular formula C21H29CL2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 86WEQ311WF chemically known as benzenemethanol, 4-amino-3,5-dichloro-.alpha.-(((6-(2-(2-pyridinyl)ethoxy)hexyl)amino)methyl)-, (r)- but generally known as picumeterol, which bears US NIH Compound Identifier 131251. European Medicines Agency schedules Picumeterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09822MIG. The term PICUMETEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31). Most nations schedule picumeterol under HS 29333999 and SITC 51574. As of Q4 2014, PICUMETEROL remains the US FDA Preferred Term for this commodity. Picumeterol bears US NLM identifiers UMLS ID C0385780 and NCI Concept Code C76543. SMILES: C1=CC=NC(=C1)CCOCCCCCCNCC(C2=CC(=C(C(=C2)CL)N)CL)O.